Source:http://linkedlifedata.com/resource/pubmed/id/20089950
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2010-1-21
|
pubmed:abstractText |
Scavenger receptor B type I (SR-BI) plays an important role in mediating cholesterol exchange between cells, high-density lipoprotein (HDL) cholesterol, and other lipoproteins. SR-BI in hepatocytes is essential for reverse cholesterol transport and biliary secretion of HDL cholesterol; thus, it is atheroprotective. More recently, it has been discovered that the HDL-SR-BI tandem serves other functions that also likely contribute to HDL-related cardiovascular protection. A number of the latter mechanisms, particularly in endothelial cells, involve unique direct signal initiation by SR-BI that leads to the activation of diverse kinase cascades. SR-BI signaling occurs in response to plasma membrane cholesterol flux. It requires the C-terminal PDZ-interacting domain of the receptor, which mediates direct interaction with the adaptor molecule PDZK1; and the C-terminal transmembrane domain, which directly binds membrane cholesterol. In endothelium, direct SR-BI signaling in response to HDL results in enhanced production of the antiatherogenic molecule nitric oxide; in a nitric oxide-independent manner, it serves to maintain endothelial monolayer integrity. The role of SR-BI signaling in the numerous other cellular targets of HDL, including hepatocytes, macrophages, and platelets, and the basis by which SR-BI senses plasma membrane cholesterol movement to modify cell behavior are unknown. Further understanding of signaling by SR-BI will optimize the capacity to harness the mechanisms of action of HDL-SR-BI for cardiovascular benefit.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1524-4636
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
30
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
144-50
|
pubmed:dateRevised |
2010-9-15
|
pubmed:meshHeading |
pubmed-meshheading:20089950-Animals,
pubmed-meshheading:20089950-Antigens, CD36,
pubmed-meshheading:20089950-Biological Transport,
pubmed-meshheading:20089950-Cardiovascular Diseases,
pubmed-meshheading:20089950-Cholesterol,
pubmed-meshheading:20089950-Humans,
pubmed-meshheading:20089950-Lipoproteins, HDL,
pubmed-meshheading:20089950-Protein Conformation,
pubmed-meshheading:20089950-Signal Transduction,
pubmed-meshheading:20089950-Structure-Activity Relationship
|
pubmed:year |
2010
|
pubmed:articleTitle |
Signaling by the high-affinity HDL receptor scavenger receptor B type I.
|
pubmed:affiliation |
Division of Pulmonary and Vascular Biology, the Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
|
pubmed:publicationType |
Journal Article,
Review
|